SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-010826
Filing Date
2021-08-06
Accepted
2021-08-06 16:30:56
Documents
12
Period of Report
2021-08-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20210806x8k.htm   iXBRL 8-K 36957
  Complete submission text file 0001558370-21-010826.txt   154145

Data Files

Seq Description Document Type Size
2 EX-101.SCH agrx-20210806.xsd EX-101.SCH 3006
3 EX-101.LAB agrx-20210806_lab.xml EX-101.LAB 15407
4 EX-101.PRE agrx-20210806_pre.xml EX-101.PRE 9874
5 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20210806x8k_htm.xml XML 4594
Mailing Address 101 POOR FARM ROAD PRINCETON NJ 08540-1715
Business Address 101 POOR FARM ROAD PRINCETON NJ 08540-1715 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 211153345
SIC: 2834 Pharmaceutical Preparations